Associate Professor Fraser Russell has an academic appointment in the School of Health and Sport Sciences, University of the Sunshine Coast. After being awarded with a PhD from the University of Melbourne in 1994, Fraser completed successful post-doctoral appointments at Cambridge University, UK (1994-1998), University of Dunedin, NZ (1998-2000) and Queensland University, Australia (2000-2004). In 2005, Fraser joined the University of the Sunshine Coast where he undertakes research, and coordinates and lectures in Pharmacology and Biochemistry.
Fraser is an Associate Editor of BMC Complementary and Alternative Medicine. He has long-standing research interests in areas of cardiovascular pharmacology, and is Lead Investigator within a Cooperative Research Centres (CRC) “Honey, Health and Product” node to discover anti-inflammatory and anti-oxidant activity of bioactive constituents of Australian Honeys. Fraser is also Lead Investigator of a randomized, placebo-controlled clinical trial investigating the efficacy of omega-3 fatty acids in patients with abdominal aortic aneurysm. This work is supported by funding from the Wishlist Foundation, with fatty acid supplements provided by Blackmores Pty Ltd. Fraser has supervised 10 PhD candidates and 22 Honours students and has published over 50 research papers.
Fraser is an active member of Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT, 1989-present), the Australian Vascular Biology Society (AVBS, 2015-present), and the International Society for the Study of Fatty Acids and Lipids (ISSFAL, 2017-present). He is the current Program Coordinator of the Bachelor of Biomedical Science (Accelerated) and member of Cluster for Biomedical Innovations Leadership Group, and VasoActive Research Group, at USC. Fraser has contributed previously to University Governance in his capacity as Member of the Sunshine Coast Hospital Institute Research Programs Sub-Committee, University Research Committee and Animal Ethics Committee.